Trump says agreements with major drugmakers will cut prescription prices and boost U.S. investment, but economists caution ...

Big changes have come to Medicare’s prescription drug coverage, known as Part D, in 2026 that could affect how you pay for ...

President Donald Trump announced Friday that nine additional pharmaceutical companies joined its most-favored-nation pricing ...

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

Out-of-pocket costs for the first 10 Medicare-negotiated prescription drugs will fall by more than 50% on average starting ...

​In an announcement on November 25, 2025, the Centers for Medicare & Medicaid Services (CMS) revealed the new Maximum Fair ...

All community and independent pharmacies in the Optum Rx network are transitioning to cost-based contracts.

Sponsored programs help uninsured, underinsured, and Medicare patients access free or discounted life-saving prescription ...

The cost of prescription drugs is soaring. A new report shows, even during the pandemic, consumers have had to pay three times more for some of their medicines. The latest RX Price Watch Report from ...

PBMs are pivoting reimbursement models to protect pharmacies from what they say is an unsustainable status quo.

Optum Rx has signaled a shift to a cost-based pharmacy reimbursement model that's intended to have pharmacies pay more for brand-name drugs and less for generics. The model will reduce variation in ...

A bill would establish a committee to study prices and solutions to high drug costs, targeting chronic conditions.